Difference between revisions of "Directed Evolution and Synthetic Biology - Hunter Stone"

From GcatWiki
Jump to: navigation, search
(Increases in Sophistication: Three Examples of Directed Evolution Showing Promise for Synthetic Biology)
(Directed Evolution and Synthetic Biology)
 
(99 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
====Project Proposal====
 
====Project Proposal====
  
My project will focus on attempts to utilize random mutations for optimization of synthetic pathways. Mathematical modeling of synthetic pathways is a powerful, proven tool to maximize product output. However, authors have recently shown that recombinant methods can be used to discover previously unknown elements of cell metabolism that will increase product yield even further. These methods of directed evolution have also been used to create powerful tools like promoters of specific expression levels, further increasing the relevance and importance of these methods to synthetic biology.
+
My project focuses on the use of random mutations to optimize synthetic pathways. Mathematical modeling and rational engineering of synthetic pathways is a powerful, proven tool to maximize product output. However, recently a series of unbiased strategies using recombinant methods have been shown to further increase product yield. These methods, which have been referred to as directed evolution, have produced powerful new methods and approaches for the synthetic biologist.
  
 +
==Introduction - Pathway Optimization and Directed Evolution==
  
==Introduction - The Problem of Pathway Optimization==
+
Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin (Ro, 2006). In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. Initially, however, this strain was unable to produce any appreciable amount of artemisin . Keasling’s team had run into a key problem facing many projects in synthetic biology: optimization. Although we are increasingly able to express sophisticated constructs within living cells, the existence of these frameworks does not always correspond with the ability to fulfill their intended purposes efficiently and effectively.
  
 +
Keasling’s team chose to address this problem by rationally modifying the metabolism of their yeast strain. Although they were successful in increasing product yields, further optimization was required for them to meet their goals. What would be the best approach to increase product yield in this system? Were the changes the already made to the yeast’s metabolism truly the best for optimizing artemisinin output? Could changes in other distantly-related metabolic pathways have also helped to increase yields? Are there presently unknown elements in the cell affecting the new pathway which could potentially be changed? Are the enzymes in the new pathway themselves working at maximum efficiency?
  
Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin. In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. However, in order to make this pathway generate a desirable amount of product, his team also had to tweak the existing yeast metabolism to ensure enough FPP was produced to channel through the synthetic pathway. In these manipulations, Keasling’s team was addressing a problem that faces many projects in synthetic biology, especially those aimed at producing a specific product: pathway optimization. Although we are increasingly able to build sophisticated constructs within living cells, the existence of these frameworks does not always correspond with their ability to fulfill their intended purposes efficiently and effectively.
+
One technique with the potential to answer all of these questions is directed evolution.
  
To maximize the amount of FPP produced, Keasling’s team increased the expression levels of the enzymes in the mevalonte pathway ('''Fig. 1'''). He also directed FPP away from the sterol biosynthetic pathway by repressing the enzyme responsible for conversion of FPP to squalene ('''Fig. 1'''). Although their methods were effective in producing desired products, the optimization of this biosynthetic pathway was limited only to augmenting the expression levels to only the known elements in the mevalonate pathway. Indeed, the researchers indicated that the yeast strain they developed requires furthers optimization to make the drug production system more commercially feasible. What other changes to the yeast strain could enhance product formation? Were the expression levels the researchers chose truly the best for meeting their goals? Could additional changes to other pathways or protein-protein interactions have lead to increases in product formation or decreases in product consumption? Could the enzymes themselves be more efficient in their catalytic activities?
+
==Directed Evolution: The Method==
  
[[Image:FIGURE 1 KEASLING.jpg]]
+
Directed evolution is a method used to create a more efficient mutant of an existing gene, RNA, pathway or cell. The method follows these general steps:
  
'''Figure 1:''' (Ro, 2006 - Permission Pending)
+
# A library of variants of the targeted construct (''e.g.'', a gene or a cell) is generated through random changes of its genomic DNA. Methods of genetic randomization include error-prone PCR, mutagenic agents like Mutazyme, or random transposon integration.  
 
+
# The variant library goes through a process of screening or selection to reveal the most productive members of the library. Selection and screening techniques are specific to desired function of each experiment (''e.g.'' higher enzyme efficiency, greater cell resistance to ethanol).
==The Theory of Directed Evolution==
+
# The most productive variant is resubmitted to the genetic randomization and selection processes.  
 
+
# Steps 1-3 are repeated until the desired result is received - an evolved mutant more adept at the processes it was selected for than its unevolved parent.  
One strategy that has the potential of addressing many of these questions within the context of synthetically constructed pathways is directed evolution. The directed evolution approach uses nature’s selective capabilities to test a large number of variants in a studied organism, pathway, or enzyme to find variants that confer greater efficiency. First, a large library of variants in the targeted gene, pathway, or cell is generated using methods that randomly change genomic DNA, such as error-prone PCR or transposon integration. In vivo tests with cells and pathways or in vitro tests with individual genes reveal the most productive members of this variant library, which are then resubmitted to the processes of genomic randomization and selection. The desired result of multiple rounds of directed evolution is a mutant more adept at the processes it was selected for than the wild-type it was derived from.
 
  
 
[[Image:DIRECTEDEVOLUTION.jpg]]
 
[[Image:DIRECTEDEVOLUTION.jpg]]
  
The power of directed evolution tests comes from two sources: their nonbiased nature and their capability to probe regions of the cell currently undescribed or beyond the present capabilities of linear modeling and reasoning.
+
==Directed Evolution and Synthetic Biology==
 
 
==Proof of Concept: Directed Evolution vs. Rational Modeling in Lycopene-producing ''E. coli''==
 
 
 
Both of these ideas were recently demonstrated in the work of researchers Hal Alper and Greg Stephanopoulos. Previously, the two researchers had created a strain of E. coli capable of synthesizing lycopene, a carotenoid which naturally occurs in tomatoes but has more recently been incorporated into vitamin tablets for its antioxidant capabilities. The team was interested in how two different sets of gene knockouts, one predicted by computer modeling and the other selected through directed evolution tests, compared in their ability to increase this strain’s lycopene production. They were also interested in whether these two types of gene knockouts would have additive effects and increase lycopene production more if they were expressed together.
 
 
 
To answer both of these questions, the researchers first used a previously described computer model to identify eight gene knockouts that were predicted to increase lycopene production. They complimented these experiments with an in vivo directed evolution test to indentify a second set of knockout sites. This test used transposon integration to create a library of random genome-wide gene knockout strains. The best of these knockout strains were selected through plating, which revealed lycopene production efficiency as a function of red colony color. This directed evolution test selected three gene knockout sites.
 
 
 
By combining all permutations of these three knockouts (one, two, and three gene knockouts) and their parental strain with the eight model-predicted knockouts in all possible ways, the researchers created 64 unique strains of bacteria to examine how randomly selected and systematically predicted gene knockouts might interact to increase lycopene production. Of the two maximum lycopene-producing strains (measured through absorbance of extracted lycopene at 475 nm), one strain had a knockout selected through directed evolution testing ('''Fig. 2a'''). Furthermore, this particular knockout strain also showed an earlier peak in lycopene production when compared to the completely stystematically-predicted knockout strain in batch fed culture ('''Fig. 2b''').
 
  
[[Image:FIGURE_2_LYCOPENE.jpg]]
+
The power of directed evolution comes from two sources: its nonbiased nature and its ability to test changes in elements of the cell beyond present knowledge and understanding. The method has historically been used to maximize the function of a particular protein. New methods have been developed recently to maximize the function not just of a single protein, but of more complex phenotypes. Using directed evolution to improve both proteins and these more complex phenotypes like enzymatic pathways has tremendous promise for synthetic biology.
  
(Alper, 2005 - Permission Pending)
+
===Optimization of Enzyme Function===
  
'''Figure 2''': The two measurements lycopene production in knockout strains of lycopene producing bacteria. ('''a''') A landscape displaying the 64 strains resulting for all possible combinations of gene knockouts selected through systematic modeling and directed evolution (combinatorial knockouts). Lycopene production for each strain was measured at the end of a 48-h shake-flask fermentation and amount of lycopene produced was quantified through extraction form the cell pellet with acetone and supernatant absorbance at 475 nm. Of interest is global maximum strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'', which contains a knockout of the Δ''PyjiD'' gene selected through directed evolution testing. ('''b''') Lycopene production of the best knockout strains in batch-fed culture. From left to right, the K12 strain from which combinatorial mutants were derived, the preengineered parental strain from which the systematically-selected knockout strains were derived, global maximum strain Δ''gdhA'' Δ''aceE'' Δ''fdhF'', global maximum strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'', and the global minimum strain and two local maximum strains from landscape 1a. Of interest is knockout strain Δ''gdhA'' Δ''aceE'' Δ''PyjiD'' (fourth from the left). This strain, which has a gene knockout selected through directed evolution testing, shows the same maximum in lycopene productivity as the entirely systematically-predicted strain Δ''gdhA'' Δ''aceE'' Δ''fdhF'' (third from left), but also shows an earlier peak in this productivity and more sustained lycopene production.
+
Many projects in synthetic biology involve introducing foreign enzymatic pathways into microbes to produce a desired product. Examples include yeast cells engineered to produce atremisinin (Ro ''et al.'', 2006) or microbes engineered to produce fossil fuels ([http://www.amyrisbiotech.com/ Amyris], [http://www.ls9.com/ LS9]). The quantity of output from these pathways ultimately depends on the efficiency of the enzymes introduced. However, rational reengineering of these enzymes is an extremely difficult task due to the complexities of protein structure as well as the lack of sufficient knowledge regarding the relationship between protein structure and funtion.  
  
==Increases in Sophistication: Three Examples of Directed Evolution Showing Promise for Synthetic Biology==
+
Two papers describe successful use of directed evolution to improve product yield by augmenting enzymatic function. In both papers, the authors circumvent the laborious task of rational protein engineering by using directed evolution. In addition, the papers describe improvements in genetic randomization and selection to maximize enzyme function.
  
'''Neuenschwander, M., M. Butz, C. Heintz & D. Hilvert. 2007. A simple selection strategy for evolving highly efficient enzymes. ''Nature Biotechnology'' 25(10): 1145-1147.'''
 
  
[[Image:EFFICIENTENZYME.jpg]]
+
[[Semi-Synthetic DNA Shuffling and Doramectin]]
  
[[Image:efficient_enzyme_data.jpg]]
+
[[A Simple Method for Highly Evolved Enzymes]]
  
<small>(Neuenschwander, 2007 - Permission Pending)</small>
+
==="Genome-wide" Directed Evolution===
  
'''Stutzman-Engwall, K., S. Conlon, R. Fedechko, H. McArthur, K. Pekrun, Y. Chen, S. Jenne, C. La, N. Trinh, S. Kim, Y. Zhang, R. Fox, C. Gustafsson & A. Krebber. 2005. Semi-synthetic DNA shuffling of ''ave''C leads to improved industrial scale production of doramectin by ''Streptomyces avermitilis''. ''Metabolic Engineering'' 7: 27-37.'''
+
A second, emerging branch of directed evolution attempts to improve phenotypes regulated not just by an individual gene but by multiple genes across the entire genome.  
  
[[Image:SHUFFLING_SCHEME.jpg]]
+
This type of directed evolution provides a method to test changes in many different elements of a cell that make up a system. Attempts at directed evolution on such a scale are relatively new. The following papers describe the use of "genome-wide" directed evolution to improve product yield from complex pathways. So long as improvements can be screened and selected for, these methods might also be applied to improvement and optimization of complex synthetic phenotypes engineered by humans, such as cellular circuitry using an array of [[Logic Gates - Emma Garren|Logic Gates]].
  
<small>(Stemmer, 1994 - Permission Pending)</small>
 
  
[[Image:DORAMECTIN2.jpg]]
+
[[Random Gene Knockout to Maximize Product Yield]]
  
<small>(Stutzman-Engwall, 2005 - Permission Pending)</small>
+
[[Global Transcriptome Machinery Engineering]]
  
 +
==Conclusion==
  
'''Alper, H., J. Moxley, E. Nevoigt, G.R. Fink & G. Stephanopoulos. 2006. Engineering yeast transcription machinery for improved ethanol tolerance and production. ''Science'' 314: 1565-1568.
+
Researchers Stutzman-Engwall ''et al.'', Neuenschwander ''et al.'', and Alper ''et al''. have all described successful uses of a general method of engineering called directed evolution to improve desired phenotypes. At no point during these experiments did the researchers draw a model or plan specific changes to genetic code to engineer these phenotypes. Some might say that for this reason directed evolution does not belong within the realm of synythetic biology. At the same time, if synthetic biology is the “engineer’s approach to biology,” then what is an engineer ultimately concerned with except the production of a useful product that meets a need? The research described in the four papers reviewed certainly meets this criterion. Furthermore, the work by Stuzman-Engwall ''et al.'' and Neuenschwander ''et al.'' indicates that directed evolution is, in its own way, becoming an increasingly planned and rational process. Semi-synthetic DNA shuffling allows the researcher to which mutations stay in wheels of genetic randomization and selection, while the “selection vector” described in the work of Neuenschwander et al. allows the researcher to precisely control selective pressure on the enzyme being evolved.
  
[[Image:FIGURE_ETHANOL.jpg]]
+
Perhaps the best strategy is to leave the definitions aside. Alper’s team has shown in lycopene-producing ''E. coli'' that directed evolution can work in concert with traditonal synthetic modeling to meet overaching goals. The two methods appear well suited for one another. Directed evolution cannot be used to engineer new and creative permutations of enzymes like in Jay Keasling’s artemisinic acid-producing yeast; however, as shown in these four papers, the method is an effective way to improve existing systems at multiple levels. On the other hand, while synthetic biology can be used to construct complex biological systems, it is not always apparent to the synthetic biologist why what he or she has engineered does not meet optimal models. Directed evolution provides the synthetic biologist with a way of testing and improving entire systems in a nonbiased manner as they try to make synthetic constructs and optimal model agree.
  
<small>(Alper, 2006 - Permission Pending)</small>
+
As these four papers have shown, when directed evolution is applied to synthetic biology, the two methods work together to create interesting, new, and, most importantly, ''optimally-functioning'' pathways.
  
 
==Works Cited==
 
==Works Cited==

Latest revision as of 16:56, 10 December 2007

Project Proposal

My project focuses on the use of random mutations to optimize synthetic pathways. Mathematical modeling and rational engineering of synthetic pathways is a powerful, proven tool to maximize product output. However, recently a series of unbiased strategies using recombinant methods have been shown to further increase product yield. These methods, which have been referred to as directed evolution, have produced powerful new methods and approaches for the synthetic biologist.

Introduction - Pathway Optimization and Directed Evolution

Researcher Jay Keasling has recently described a genetically-modified yeast strain that produces artemisinic acid, a chemical precursor to the antimalarial drug artemisinin (Ro, 2006). In these experiments, his team engineered yeast cells to express enzymes in a pathway that converts farnesyl pyrophosphate (FPP), a metabolic intermediate naturally occurring in yeast, into the desired product. Initially, however, this strain was unable to produce any appreciable amount of artemisin . Keasling’s team had run into a key problem facing many projects in synthetic biology: optimization. Although we are increasingly able to express sophisticated constructs within living cells, the existence of these frameworks does not always correspond with the ability to fulfill their intended purposes efficiently and effectively.

Keasling’s team chose to address this problem by rationally modifying the metabolism of their yeast strain. Although they were successful in increasing product yields, further optimization was required for them to meet their goals. What would be the best approach to increase product yield in this system? Were the changes the already made to the yeast’s metabolism truly the best for optimizing artemisinin output? Could changes in other distantly-related metabolic pathways have also helped to increase yields? Are there presently unknown elements in the cell affecting the new pathway which could potentially be changed? Are the enzymes in the new pathway themselves working at maximum efficiency?

One technique with the potential to answer all of these questions is directed evolution.

Directed Evolution: The Method

Directed evolution is a method used to create a more efficient mutant of an existing gene, RNA, pathway or cell. The method follows these general steps:

  1. A library of variants of the targeted construct (e.g., a gene or a cell) is generated through random changes of its genomic DNA. Methods of genetic randomization include error-prone PCR, mutagenic agents like Mutazyme, or random transposon integration.
  2. The variant library goes through a process of screening or selection to reveal the most productive members of the library. Selection and screening techniques are specific to desired function of each experiment (e.g. higher enzyme efficiency, greater cell resistance to ethanol).
  3. The most productive variant is resubmitted to the genetic randomization and selection processes.
  4. Steps 1-3 are repeated until the desired result is received - an evolved mutant more adept at the processes it was selected for than its unevolved parent.

DIRECTEDEVOLUTION.jpg

Directed Evolution and Synthetic Biology

The power of directed evolution comes from two sources: its nonbiased nature and its ability to test changes in elements of the cell beyond present knowledge and understanding. The method has historically been used to maximize the function of a particular protein. New methods have been developed recently to maximize the function not just of a single protein, but of more complex phenotypes. Using directed evolution to improve both proteins and these more complex phenotypes like enzymatic pathways has tremendous promise for synthetic biology.

Optimization of Enzyme Function

Many projects in synthetic biology involve introducing foreign enzymatic pathways into microbes to produce a desired product. Examples include yeast cells engineered to produce atremisinin (Ro et al., 2006) or microbes engineered to produce fossil fuels (Amyris, LS9). The quantity of output from these pathways ultimately depends on the efficiency of the enzymes introduced. However, rational reengineering of these enzymes is an extremely difficult task due to the complexities of protein structure as well as the lack of sufficient knowledge regarding the relationship between protein structure and funtion.

Two papers describe successful use of directed evolution to improve product yield by augmenting enzymatic function. In both papers, the authors circumvent the laborious task of rational protein engineering by using directed evolution. In addition, the papers describe improvements in genetic randomization and selection to maximize enzyme function.


Semi-Synthetic DNA Shuffling and Doramectin

A Simple Method for Highly Evolved Enzymes

"Genome-wide" Directed Evolution

A second, emerging branch of directed evolution attempts to improve phenotypes regulated not just by an individual gene but by multiple genes across the entire genome.

This type of directed evolution provides a method to test changes in many different elements of a cell that make up a system. Attempts at directed evolution on such a scale are relatively new. The following papers describe the use of "genome-wide" directed evolution to improve product yield from complex pathways. So long as improvements can be screened and selected for, these methods might also be applied to improvement and optimization of complex synthetic phenotypes engineered by humans, such as cellular circuitry using an array of Logic Gates.


Random Gene Knockout to Maximize Product Yield

Global Transcriptome Machinery Engineering

Conclusion

Researchers Stutzman-Engwall et al., Neuenschwander et al., and Alper et al. have all described successful uses of a general method of engineering called directed evolution to improve desired phenotypes. At no point during these experiments did the researchers draw a model or plan specific changes to genetic code to engineer these phenotypes. Some might say that for this reason directed evolution does not belong within the realm of synythetic biology. At the same time, if synthetic biology is the “engineer’s approach to biology,” then what is an engineer ultimately concerned with except the production of a useful product that meets a need? The research described in the four papers reviewed certainly meets this criterion. Furthermore, the work by Stuzman-Engwall et al. and Neuenschwander et al. indicates that directed evolution is, in its own way, becoming an increasingly planned and rational process. Semi-synthetic DNA shuffling allows the researcher to which mutations stay in wheels of genetic randomization and selection, while the “selection vector” described in the work of Neuenschwander et al. allows the researcher to precisely control selective pressure on the enzyme being evolved.

Perhaps the best strategy is to leave the definitions aside. Alper’s team has shown in lycopene-producing E. coli that directed evolution can work in concert with traditonal synthetic modeling to meet overaching goals. The two methods appear well suited for one another. Directed evolution cannot be used to engineer new and creative permutations of enzymes like in Jay Keasling’s artemisinic acid-producing yeast; however, as shown in these four papers, the method is an effective way to improve existing systems at multiple levels. On the other hand, while synthetic biology can be used to construct complex biological systems, it is not always apparent to the synthetic biologist why what he or she has engineered does not meet optimal models. Directed evolution provides the synthetic biologist with a way of testing and improving entire systems in a nonbiased manner as they try to make synthetic constructs and optimal model agree.

As these four papers have shown, when directed evolution is applied to synthetic biology, the two methods work together to create interesting, new, and, most importantly, optimally-functioning pathways.

Works Cited

Alper, H, K. Miyaoku & G. Stephanopoulos. 2005. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nature Biotechnology 23(5): 612-616.

Alper, H., J. Moxley, E. Nevoigt, G.R. Fink & G. Stephanopoulos. 2006. Engineering yeast transcription machinery for improved ethanol tolerance and production. Science 314: 1565-1568.

Neuenschwander, M., M. Butz, C. Heintz & D. Hilvert. 2007. A simple selection strategy for evolving highly efficient enzymes. Nature Biotechnology 25(10): 1145-1147.

Ro D, E.M. Paradise, M. Ouellet, K.J. Fisher, K.L. Newman, J.M. Ndungu, K.A. Ho, R.A. Eachus, T.S. Ham, J. Kirby, M.C.Y. Chang, S.T. Withers, Y. Shiba, R. Sarpong & J.D. Keasling. 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 940-43.

Stemmer, W.P.C. 1994. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. PNAS 91: 10747-10751

Stutzman-Engwall, K., S. Conlon, R. Fedechko, H. McArthur, K. Pekrun, Y. Chen, S. Jenne, C. La, N. Trinh, S. Kim, Y. Zhang, R. Fox, C. Gustafsson & A. Krebber. 2005. Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis. Metabolic Engineering 7: 27-37.